Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Skye Bioscience, Inc. | 8,167,206 | reported | 13 Sept 2024 | tx 6−266,337 |
| Camp4 Therapeutics Corp | 2,941,176 | reported | 11 Sept 2025 | tx 1+2,941,176 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Sept 2025 | PURCHASE | Camp4 Therapeutics Corp | 2,941,176 | 1.53 USD | |
| 11 Sept 2024 | SALE | Skye Bioscience, Inc. | 1,440 | 6.60 USD | |
| 13 Sept 2024 | SALE | Skye Bioscience, Inc. | 11,758 | 6.06 USD | |
| 11 Sept 2024 | SALE | Skye Bioscience, Inc. | 214,556 | 6.60 USD | |
| 11 Sept 2024 | SALE | Skye Bioscience, Inc. | 36,504 | 6.60 USD | |
| 13 Sept 2024 | SALE | Skye Bioscience, Inc. | 2,000 | 6.06 USD | |
| 13 Sept 2024 | SALE | Skye Bioscience, Inc. | 79 | 6.06 USD |